You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海爾生物(688139.SH):未來將持續加強自動化技術與科研醫療場景的融合
格隆匯 07-27 08:37

格隆匯7月27日丨海爾生物(688139.SH)近期在接待機構投資者調研時表示,自動化技術在生命科學與醫療創新領域獲得越來越多的應用,自動化平台通過一致性、標準化、高效率的貢獻,為科研及醫療工作提供了核心推動力,加速成果產出,提高工作效率。公司將自動化技術列為核心技術平台,在以下領域加速佈局。在樣本存儲領域,結合公司優勢的低温製冷平台,研發了-80℃、-196℃系列化樣本庫,滿足不同容量、不同品類樣本的自動化存儲管理;在樣本處理領域,研發樣本自動化處理工作站,實現樣本的批量分裝、提取等過程的自動化處理,並結合AGV機器人,實現樣本庫的無人化管理。

在生物培養方面,研發了細胞工作站,針對細胞治療應用場景,可以實現細胞插入、細胞觀察、換液、消化、傳代、培養全過程自動化,提供批量細胞高一致性培養解決方案。在醫療服務領域,還研發了自動化血液庫、自動化疫苗工作站,為血液管理、安全接種提供高效、安全的解決方案;與公司新併購公司厚宏智能的自動化藥房產品形成協同,為醫療場景提供更全面的自動化解決方案。未來,公司還將持續加強自動化技術與科研醫療場景的融合,突破行業“卡脖子”難題,讓自動化技術賦能更多產業場景。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account